questionText: To ask the Secretary of State for Health and Social Care, what steps the Government is taking through the UK Life Sciences Industrial Strategy to prevent incentives or regulatory reforms from enabling large pharmaceutical companies to increase medicine pr
answerText: The Voluntary Scheme for Branded Medicines Pricing, Access and Growth (VPAG) controls the cost of sales of branded medicines to the National Health Service. The VPAG has a variable headline payment percentage, which accounts for changes to the cost of med...
heading: Drugs: Prices